Help is on the way: Monoclonal antibody therapy for multi-drug resistant bacteria.
作者信息
Babb Rachelle, Pirofski Liise-Anne
机构信息
a Division of Infectious Diseases, Department of Medicine , Albert Einstein College of Medicine and Montefiore Medical Center , Bronx, New York , NY , USA.
出版信息
Virulence. 2017 Oct 3;8(7):1055-1058. doi: 10.1080/21505594.2017.1306620. Epub 2017 Mar 17.
Abstract
摘要
相似文献
1
Help is on the way: Monoclonal antibody therapy for multi-drug resistant bacteria.援助即将到来：针对多重耐药菌的单克隆抗体疗法。
Virulence. 2017 Oct 3;8(7):1055-1058. doi: 10.1080/21505594.2017.1306620. Epub 2017 Mar 17.
2
Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria.辅助转铁蛋白减少革兰氏阴性菌的抗生素耐药性出现。
J Antimicrob Chemother. 2019 Sep 1;74(9):2631-2639. doi: 10.1093/jac/dkz225.
3
Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates.革兰氏阴性杆菌和肺炎克雷伯菌分离株中产黏菌素耐药的危险因素。
J Clin Microbiol. 2018 Aug 27;56(9). doi: 10.1128/JCM.00149-18. Print 2018 Sep.
4
Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.基于 2014 年中国 153 家三级医院的数据，探讨抗生素使用与碳青霉烯类耐药革兰氏阴性菌发生率之间的关系。
Antimicrob Resist Infect Control. 2018 Nov 19;7:137. doi: 10.1186/s13756-018-0430-1. eCollection 2018.
5
Antibacterial and antibiotic-resistance modifying activity of the extracts and compounds from Nauclea pobeguinii against Gram-negative multi-drug resistant phenotypes.诺氏乌檀提取物及化合物对革兰氏阴性多药耐药表型的抗菌及抗生素耐药性修饰活性
BMC Complement Altern Med. 2016 Jul 7;16:193. doi: 10.1186/s12906-016-1173-2.
6
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.多粘菌素作为抗多重耐药革兰氏阴性菌药物的评估。
Int J Antimicrob Agents. 2005 Jan;25(1):11-25. doi: 10.1016/j.ijantimicag.2004.10.001.
7
Isopedopeptins A-H: Cationic Cyclic Lipodepsipeptides from UP508 Targeting WHO Top-Priority Carbapenem-Resistant Bacteria.异哌多肽 A-H：靶向世界卫生组织优先考虑的碳青霉烯类耐药菌的阳离子环状脂环二肽。
ACS Chem Biol. 2020 Nov 20;15(11):2937-2944. doi: 10.1021/acschembio.0c00568. Epub 2020 Oct 14.
8
9
Antimicrobial resistance patterns of Gram-negative bacteria isolated from bloodstream infections in an Iranian referral paediatric hospital: A 5.5-year study.从伊朗一家儿科转诊医院血流感染中分离的革兰氏阴性菌的抗菌药物耐药模式：一项为期 5.5 年的研究。
J Glob Antimicrob Resist. 2017 Dec;11:17-22. doi: 10.1016/j.jgar.2017.04.013. Epub 2017 Jul 17.
10
Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008.2006-2008 年全国医疗保健安全网络报告的引起医疗保健相关感染的革兰氏阴性病原体的多药耐药性。
Infect Control Hosp Epidemiol. 2010 May;31(5):528-31. doi: 10.1086/652152.
引用本文的文献
1
Development of a Bispecific Antibody Targeting Clinical Isolates of Acinetobacter baumannii.开发一种针对鲍曼不动杆菌临床分离株的双特异性抗体。
J Infect Dis. 2023 Apr 26;227(9):1042-1049. doi: 10.1093/infdis/jiac499.
2
Intradermal Immunization with Heat-Killed Leading to the Production of Protective Immunoglobulin G in BALB/c Mice.用热灭活菌进行皮内免疫可使BALB/c小鼠产生保护性免疫球蛋白G 。
Int J Appl Basic Med Res. 2021 Jul-Sep;11(3):160-165. doi: 10.4103/ijabmr.IJABMR_63_20. Epub 2021 Jul 19.
3
Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection.单克隆抗体需要免疫调节以对抗鲍曼不动杆菌感染的疗效。
J Infect Dis. 2021 Dec 15;224(12):2133-2147. doi: 10.1093/infdis/jiab265.
4
Fusogenic porous silicon nanoparticles as a broad-spectrum immunotherapy against bacterial infections.融合多孔硅纳米粒子作为广谱抗细菌感染免疫疗法。
Nanoscale Horiz. 2021 Apr 1;6(4):330-340. doi: 10.1039/d0nh00624f. Epub 2021 Feb 18.
5
Pulling the Brakes on Fast and Furious Multiple Drug-Resistant (MDR) Bacteria.遏制快速传播和耐药性多重耐药（MDR）细菌。
Int J Mol Sci. 2021 Jan 16;22(2):859. doi: 10.3390/ijms22020859.
6
A Diverse Panel of Clinical Acinetobacter baumannii for Research and Development.用于研究和开发的临床鲍曼不动杆菌多样化小组。
Antimicrob Agents Chemother. 2020 Sep 21;64(10). doi: 10.1128/AAC.00840-20.
7
Evaluation of Recombinant Multi-Epitope Outer Membrane Protein-Based Subunit Vaccine in Mouse Model.基于重组多表位外膜蛋白的亚单位疫苗在小鼠模型中的评价
Front Microbiol. 2017 Sep 20;8:1805. doi: 10.3389/fmicb.2017.01805. eCollection 2017.
本文引用的文献
1
Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against Klebsiella pneumoniae ST258.O抗原特异性单克隆抗体对内毒素的中和作用：一种针对肺炎克雷伯菌ST258的潜在新型治疗方法。
Virulence. 2017 Oct 3;8(7):1203-1215. doi: 10.1080/21505594.2017.1279778. Epub 2017 Jan 19.
2
Notes from the Field: Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae - Washoe County, Nevada, 2016.实地记录：产泛耐药新德里金属β-内酰胺酶的肺炎克雷伯菌——内华达州瓦肖县，2016年
MMWR Morb Mortal Wkly Rep. 2017 Jan 13;66(1):33. doi: 10.15585/mmwr.mm6601a7.
3
Antibody-Based Immunotherapy To Treat and Prevent Infection with Hypervirulent Klebsiella pneumoniae.基于抗体的免疫疗法治疗和预防高毒力肺炎克雷伯菌感染
Clin Vaccine Immunol. 2017 Jan 5;24(1). doi: 10.1128/CVI.00456-16. Print 2017 Jan.
4
Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage.抗荚膜多糖抗体的凝集作用与预防实验性人类肺炎球菌携带有关。
Mucosal Immunol. 2017 Mar;10(2):385-394. doi: 10.1038/mi.2016.71. Epub 2016 Aug 31.
5
Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody.非调理素性荚膜多糖抗体对肺炎链球菌定植与播散的抑制作用
mBio. 2016 Feb 2;7(1):e02260-15. doi: 10.1128/mBio.02260-15.
6
Both clades of the epidemic KPC-producing Klebsiella pneumoniae clone ST258 share a modified galactan O-antigen type.产KPC的流行肺炎克雷伯菌克隆ST258的两个进化枝都具有一种修饰的半乳聚糖O抗原类型。
Int J Med Microbiol. 2016 Feb;306(2):89-98. doi: 10.1016/j.ijmm.2015.12.002. Epub 2015 Dec 15.
7
Antibody blocks acquisition of bacterial colonization through agglutination.抗体通过凝集作用阻止细菌定植的获得。
Mucosal Immunol. 2015 Jan;8(1):176-85. doi: 10.1038/mi.2014.55. Epub 2014 Jun 25.
8
Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect.迈向抗内毒素抗体的临床应用；重新评估脱节之处。
Toxins (Basel). 2013 Dec 18;5(12):2589-620. doi: 10.3390/toxins5122589.
9
Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia.抗α-毒素单克隆抗体预防和治疗金黄色葡萄球菌诱导性肺炎的评估。
Antimicrob Agents Chemother. 2014;58(2):1108-17. doi: 10.1128/AAC.02190-13. Epub 2013 Dec 2.
10
Therapeutic human monoclonal antibodies in inflammatory diseases.用于炎症性疾病的治疗性人源单克隆抗体。
Methods Mol Biol. 2014;1060:37-59. doi: 10.1007/978-1-62703-586-6_3.
Zotero 插件